Are you looking to adopt Magtrace into your practice? Or perhaps you're already using and want to find out how to further optimise? Watch @KarakatsanisA as he shares his tips on where, when and why you should inject Magtrace for even better results. Watch at #TBCCOnDemand👇

“With these [Magseed and Magtrace] procedures, we can remove less breast tissue and can be more confident that the margins are negative." Dr Christian Zwick explains how utilizing the full Sentimag platform is driving improved surgical outcomes for Quincy Medical Group patients.

What if you could save 80% of your DCIS patients from undergoing unnecessary axillary surgery? This week we'll be at #ASBrS23 with our #SaveOurNodes booth raising awareness of the Delayed Sentinel Lymph Node Biopsy technique. Until then, learn all about dSLNB over at @Breast360

More big news... From 1st January 2023, Endomag will become sole distributor of the Sentimag® system in the UK, France, Germany and Scandinavia. Find out more below👇(1/7) https://t.co/ikOAfW8HSv

It's finally here... 𝐌𝐚𝐠𝐭𝐫𝐚𝐜𝐞 𝐫𝐞𝐜𝐞𝐢𝐯𝐞𝐬 𝐅𝐃𝐀 𝐚𝐩𝐩𝐫𝐨𝐯𝐚𝐥 𝐟𝐨𝐫 𝐞𝐱𝐭𝐞𝐧𝐝𝐞𝐝 𝐥𝐮𝐦𝐩𝐞𝐜𝐭𝐨𝐦𝐲 𝐢𝐧𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧! Read more 👇

If ongoing shortages of Tc99 are now affecting your ability to perform sentinel lymph node biopsy, we have a simple solution. Magtrace is a @NICEComms approved non-inferior alternative, ready to help support your unit. To find out more, get in touch:

🎯 1,000 Magseed placements vs 1,000 Wires - which comes out on top? 🌎 Sentimag experiences from three different continents 💯 A complete magnetic TAD approach Hear the latest insights from this year's CoBrCa 2022 symposium, featuring @RVDSurgeon, @DrJDietz and @mdAlvaradoMD👇

Make sure to join us in an hour's time! #EBCC13

Magtrace® has officially received a guidance recommendation from the @NICEComms, for use in SLNB. NICE acknowledge this could be a significant breakthrough in breast cancer staging, with the potential to drastically improve NHS breast cancer operations. Find out more 👇

The #MagTeamChallenge returns! Everyone deserves a better standard of cancer care, including access to the best resources and community support. So this October, we've partnered with @The_Breasties for another epic fundraising challenge. 25k miles to raise $25k – are you in?

It's great to be back at @LDN_BM 2022 once again!  Looking forward to hearing the experiences of the international panels on stage, and meeting with attendees at our booth. Make sure to pop by and say hello if you're here!  #LBM2022

🗣️ "It's another great tool to help further personalize breast cancer care"  Dr. Valerie Brutus of @StVincentsMC explains how Magtrace® gives her patients more choice, and offers the opportunity to avoid axillary surgery altogether.  See more, here:

Finding a lump can be an anxiety-ridden experience for anyone. So we asked four leading surgeons to share their top tips for breast cancer detection, including the importance of early detection, understanding family history and other symptoms to be aware of. Read more here👇

Nuvance Health now offers a #breastcancer surgical technique – Magtrace® lymphatic tracer – that greatly reduces a patient's chance of developing #lymphedema after a #mastectomy to treat ductal carcinoma in situ (DCIS). Learn more: https://t.co/dNndRVrDQT

"Cancer is a big, scary word" When Mitzi Barhorst was diagnosed earlier this year, she was prepared for an invasive course of treatment. But thanks to the pioneering team at @StVincentsMC and Magtrace®, Mitzi was able to avoid an unnecessary surgical procedure. Watch below.

Delayed sentinel lymph node biopsy is helping to decrease the need for axillary (lymph node) surgery in up to 80% of patients with high-risk Ductal Carcinoma In-Situ (DCIS), and reduce the chances of long-lasting conditions such as lymphedema. @endomag https://t.co/UD5h3sW5DP

. @stvincentsmc started using a product called @Magtrace, which aims to limit the unnecessary removal of #lymphnodes and reduce the risk of #lymphedema in #breastcancer patients. https://t.co/0Zls1sIUWP via @nhregister

🗣️ “Magseed offers a leap forward in breast cancer localization technology” Jefferson County Health Center has become one the latest sites to adopt Magseed®, introducing the innovative breast cancer technology to Southeast Iowa.  Read more here:

New study findings 🔎 A recent comparative cross-centre study demonstrates SLNB to be as accurate when using Magtrace® (lymph node detection rate of 98.13%) as it is for the 'gold standard' of Tc-99 and blue dye (92.26%). Read the full study below 👇

Did you know Magtrace® is also used for Melanoma staging? Find out how this novel lymphatic tracer is helping to better diagnose and treat patients for both skin and breast cancers in Guernsey - without them having to leave their island. Read more on the story below.